Key Financial Data Of Reporting Company

Delta-Fly Pharma, Inc. - Filing #7713831

Concept As at
2018-12-31
2018-10-01 to
2018-12-31
2018-04-01 to
2018-12-31
As at
2018-03-31
2017-04-01 to
2018-03-31
Key financial data of reporting company
Business results of reporting company
Ordinary profit (loss)
-501,880,000 JPY
-244,505,000 JPY
Profit (loss)
-503,528,000 JPY
-246,268,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
Share capital
2,795,185,000 JPY
1,117,500,000 JPY
Total number of issued shares
4,369,600 xbrli:shares
5,635 xbrli:shares
Net assets
3,674,335,000 JPY
822,493,000 JPY
Total assets
3,721,295,000 JPY
864,145,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-52.75
-131.63
-71.20
Diluted earnings per share
Equity-to-asset ratio
0.987 xbrli:pure
0.952 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.